vs
Side-by-side financial comparison of Biodexa Pharmaceuticals Plc (BDRX) and Sanofi (SNY). Click either name above to swap in a different company.
Biodexa Pharmaceuticals Plc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, including epilepsy and rare neurodegenerative conditions. It operates primarily across European and North American markets, advancing multiple pipeline candidates through clinical trials to address unmet patient needs.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of th...
